Cargando…
Research Progress of Drug Treatment in Novel Coronavirus Pneumonia
As of March 10, 2020, more than 100,000 novel coronavirus pneumonia cases have been confirmed globally. With the continuous spread of the new coronavirus pneumonia epidemic in even the world, prevention and treatment of the disease have become urgent tasks. The drugs currently being developed are no...
Autores principales: | Yan, Junqiang, Liu, Anran, Huang, Jiarui, Wu, Jiannan, Fan, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220569/ https://www.ncbi.nlm.nih.gov/pubmed/32405780 http://dx.doi.org/10.1208/s12249-020-01679-z |
Ejemplares similares
-
Nur77 attenuates inflammatory responses and oxidative stress by inhibiting phosphorylated IκB-α in Parkinson’s disease cell model
por: Yan, Junqiang, et al.
Publicado: (2020) -
Efficacy and Safety of Rotigotine Transdermal Patch on Neuropsychiatric Symptoms of Parkinson's Disease: An Updated Meta-Analysis and Systematic Review
por: Yan, Junqiang, et al.
Publicado: (2021) -
Pharmacological Interventions for REM Sleep Behavior Disorder in Parkinson's Disease: A Systematic Review
por: Yan, Junqiang, et al.
Publicado: (2021) -
Effect of statins on Parkinson's disease: A systematic review and meta-analysis
por: Yan, Junqiang, et al.
Publicado: (2019) -
Atorvastatin improves motor function, anxiety and depression by NOX2-mediated autophagy and oxidative stress in MPTP-lesioned mice
por: Yan, Junqiang, et al.
Publicado: (2020)